Blue Horseshoe Stocks

Blue Horseshoe Stocks: Options Update, GALT Recap & More

Whole Foods Market, Inc. WFM – Options Update

We just wanted to circle back for our WFM options idea that we submitted last week. We designated contracts with a 02/17 expiration instead of weeklies to give our idea time to develop and it ended up being a good call. Our targets were the WFM 02/17 $30 and 30.50 Calls.

Yesterday WFM had a morning pullback which was followed by a nice reversal, and the stock ended up bulling its way into the close near its high of day. The calls we signaled last week had a significant move as a result. The $30 Calls ran from .14-.52 (+271%), while the $30.50’s exploded from .05-.21 (+320%). We are going to want to keep them on our radar for the rest of the week into expiration.

Key resistance is at the 200DMA and 50DMA of 30.38 and 30.76, respectively. If WFM can crack the latter, we may look to roll our strike price up and push out another week to contracts expiring next Friday- particularly, the WFM 02/24 $31 Calls.

Galectin Therapeutics, Inc. GALT

We’ve now witnessed quite a run from GALT over the past few weeks, validating our previous reports on the stock wherein we contested that a serious run-up appeared likely.

It began with our report on 01/12, in which we noted GALT’s ripening chart, and surmised that forthcoming gains of 100% were not out of the question. We observed a low of .935 subsequent to that followed by a nice 38% push to 1.29 leading into our most recent report on GALT last Friday.

In that report we had this to say “We feel these gains are sustainable if GALT can manage to crack past the current 200DMA at 1.32. As you can see on the included snapshot, the chart continues to bear the look of potential for even further increases“.

Yesterday GALT met those expectations nicely with a run to a new high of 1.85, which marks an overall increase from our observed low of 98%, falling just a hair shy of our initial speculations. Yet, our prediction seems to be coming full circle this morning as the stock is gearing up to fill its gap on the chart that we pointed out in our initial report. One more bullish push will get us into double-bagger territory for this idea, and the stock may well make a run well into the 2.00-range.

Green EnviroTech Holdings Corp. GETH – Recap

We were quite pleased with the performance of GETH following our featured report yesterday morning, as the stock provided traders with a pair of solid intraday swings amid an onslaught of volume.

Right from the opening bell, GETH shot up from .165 to the high of day at .235, marking an initial rip of 42% The stock subsequently pulled back to a daily low at .1514, before surging up once more to .215, matching the morning’s 42% gain exactly.

All of this useful volatility was accompanied by massive volume on the order of 39X the monthly average, or 19X the 3-month average. It represented an all-time record high for shares of GETH traded in a single session!

Yesterday we had identified .15 as the key support level that needed to hold in order to make GETH interesting, and our sentiments in that regard haven’t changed.

Extended Watchlist:
ONOV, GAHC, NNSR, BG, WIX, GRPN, EVOK,

Blue Horseshoe Stocks: GETH Special Report

Green EnviroTech Holdings Corp. GETH – Special Report

As we mentioned in yesterday’s special reminder, we’ve got a new item of interest to present this morning. That stock is GETH, which has been building on the chart over the past few sessions. A number of key indicators point to a sizable potential upside for this play, but as we always do when we take an in-depth look at a company, we want to delve into the backstory a little bit before getting to the technical aspects of the chart.

While environmentally ‘green’ plays might not be the absolute height of trendiness anymore, we’re still always on the lookout for any company whose core business not only serves itself, but the best interest of the planet as well.

As human populations rocket ever-upward, solutions for the growing amounts of waste must be embraced by everyone. That’s why we’re particularly intrigued with GETH; for its waste-to-energy process that breaks down harmful waste and extracts the by-products, particularly high grade oil, and other useful materials for sale and re-use.

Used tires and waste plastics are two of the most voluminous and harmful constituents of the growing waste problem plaguing America’s landfills, and the GETH Technology Solution for waste-to-energy (and usable raw materials) specifically targets those two elements in their treatment facilities, whose input/output highlights are specified below:

A typical Gen 1 tire processing plant with a single ‘Cell’ is expected to be capable of processing up to 1,500,000 end-of-life tires per year and producing approximately 6,000 tons of carbon black, 51,000 barrels of oil, and 1,800 tons of steel from that feedstock.

A typical Gen 1 plastic processing plant with a single ‘Cell’ is expected to be capable of processing up to 33,800,000 pounds of waste plastic per year and producing approximately 99,000 barrels of oil.

We’re extremely interested in figures like those, as we said before, because they represent a win-win for GETH and the environment!

______

GETH CHART:

We find GETH to be attractive from a technical perspective as well, with a number of key points indicating the increasing likelihood of a significant push to the upside.

The MACD is pinching in toward a bullish cross, while previous resistance coincides with the 50DMA of .232. A break past that point would leave a clear path to December’s swing-high of .40.

We’ve also prepared a short video presentation of the GETH Chart:

______

For More Info on GETH, visit: GreenEnvirotech.com

Blue Horseshoe Stocks: News Plays & Special Reminder

Aeterna Zentaris, Inc. AEZS

AEZS is gapping up this morning on the heels of some news. It’s been quite a few months since we last mentioned this stock. That was back in the fall, and we subsequently witnessed quite a surge from the stock after that.

Since then, so far in 2017 the stock has come down to record new annual lows, and recently has been making incremental increases off of that bottom. In light of today’s news, described below, we think it’s a good time to put AEZS back on a more intensive watch.

The company announced this morning, following a comprehensive review Phase 3 clinical data on Macrilen™ for the evaluation of growth hormone deficiency, that Macrilen™ demonstrated performance supportive of achieving registration with the FDA. The FDA has agreed to consider the Company’s conclusions during a Type A meeting, which is currently being scheduled. (>>View PR)

Zosano Pharma Corp. ZSAN

Speaking of fresh news plays, we also want to highlight the announcement coming from ZSAN this morning that presently has the stock gapping up in the premarket to the tune of 50%

This morning ZSAN reported that in its ZOTRIP pivotal efficacy study, the company’s M207 transdermal migraine therapy patch met both primary, as well as secondary endpoints. It certainly explains the premarket hoopla, and warrants our observation as we kick off a new trading week.

The chart also has some attractive features which we’ve pointed out on the snapshot below:

**SPECIAL REMINDER**

To wrap things up this morning, we want to leave our readers with a quick heads up on a big Tuesday coming up. We’ve got a special report coming out tomorrow prior to the opening bell. It could represent quite an opportunity, so tomorrow is definitely not the day to miss out on our premarket report!

Be sure to stay locked onto your email inboxes or BlueHorseshoeStocks.com tomorrow between 9:00 to 9:15AM, and lean on those refresh buttons!

Extended Watchlist:
MCIG, MYHI, ADVT, MJTK, QSIM, NK

Blue Horseshoe Stocks: Options, Bottom Bouncer & More

Galectin Therapeutics, Inc. GALT

This morning we’re taking a look back at GALT, which we highlighted as a ripening play that we felt was worthy of observation last month.

Our suspicion that the chart had growth in store turned out to be correct. Since we put this play on our radar it has gone on to trade in a solid range from .935 to 1.29, which works out to an increase of 38%

We feel these gains are sustainable if GALT can manage to crack past the current 200DMA at 1.32. As you can see on the included snapshot, the chart continues to bear the look of potential for even further increases, so we’ll stay on the lookout for that.

Whole Foods Market, Inc. WFM

WFM is showing some nice volatility and positive price action despite a fairly uninteresting earnings release this week.

We like to follow the activity regardless, and today it’s leading us to focus on some WFM options. Rather than selecting weekly options that will expire this afternoon, we’ll go out to contracts that expire next Friday; the WFM 02/17 $30 & $30.50 Calls.

NantKwest, Inc. NK – Bottom-Bouncer

The NK chart gave off a pretty good bottom-bounce signal yesterday and the day before, so we’ll be interested in tracking the action in this play over the next several sessions on the chance that it can string together a multi-session uptrend.

From the chart below, it’s easy to see why we feel NK could be ripe for the picking. The RSI is increasing, while the MACD is a hair’s breath away from a bullish cross that generally indicates some significant move to the upside is in the stock’s near future. We’ll have our eyes peeled for that.

Extended Watchlist:
MYHI, ICNB, INCC, SPDL, UAMM, ICPT

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Bottom-Watch Plays

We want to start things off this morning by highlighting a couple of stocks on the higher exchanges that are both currently trading at a low multiple. Stocks that trade on the NASDAQ and NYSE at less than a dollar per share for at least a month can face de-listing procedures, so companies in danger of this tend to go to great lengths to buoy their stock price.

We’re always on the lookout for possible bottom plays so we’re going to be tracking both of the following in coming sessions.

Cobalt International Energy, Inc. CIE – The de-listing alarm bells haven’t quite gone off yet at with CIE, as the PPS just fell below a buck toward the end of last month. The stock also has a recent track record of brief periods of sub-1.00 trading from which it has promptly recovered each time.

This leads us to believe that the company may not even get to the point of receiving a notice from the NYSE before share price sees a recovery. We’re going to want to be on the lookout for that potential rebound.

______

Alliqua Biomedical, Inc. ALQA – In the case of ALQA, a NASDAQ play, the situation is a bit more pressing. Shares fell below the dollar mark at the beginning of September, and the company did receive its ‘failure to satisfy listing requirement’ notice back in October. The PPS has lagged ever since, and has only until the end of April to re-attain the dollar mark, or face delisting.

We’ll be interested to follow along to see what efforts are untaken to once again satisfy listing requirements. In the meantime, the stock has found a reasonably solid base of support off of recent lows, so we’ll be on the lookout for possible rebounds.

Viacom, Inc. VIAB – Options Idea

Our regular readers know full well that we love a good earnings-related options idea, and that’s what we’ve got this morning with Viacom. The company just posted an impressive earnings beat, along with strategic guidance updates that has the stock rocking in the premarket.

We’re going to be keeping our eyes open upon the opening bell, and tracking the activity in the VIAB Weekly $44-45.50 Calls.

Extended Watchlist:
MMEG, SDVI, ISBG, ETRM, CLF, TSLA,